Imaging Diagnostic Gets Patent for Laser Imaging Device

FORT LAUDERDALE, Fla., Sept. 16 -- Imaging Diagnostic Systems Inc. announced that it has received patent issue notification from the US Patent and Trademark Office for the company's laser imaging device employing biomedical markers that bind to cancer cells. The fluorescence CTLM scanner uses fluorescent markers, which distinguish cancerous cells from healthy cells, to localize the cancerous tissue.





LATEST NEWS

• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024
• One-Step Hologram Generation Speeds 3D Display Creation
  Apr 24, 2024
• Innovation Award Winners for Laser Technology Honored in Aachen
  Apr 23, 2024
• Intech 2024: AI Arrives on the Shop Floor
  Apr 22, 2024